These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38946019)

  • 1. Promotion of maturation of human pluripotent stem cell-derived cardiomyocytes via treatment with the peroxisome proliferator-activated receptor alpha agonist Fenofibrate.
    Lee SG; Rhee J; Seok J; Kim J; Kim MW; Song GE; Park S; Jeong KS; Lee S; Lee YH; Jeong Y; Kim CY; Chung HM
    Stem Cells Transl Med; 2024 Aug; 13(8):750-762. PubMed ID: 38946019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancing Cardiovascular Drug Screening Using Human Pluripotent Stem Cell-Derived Cardiomyocytes.
    Oh J; Kwon OB; Park SW; Kim JW; Lee H; Kim YK; Choi EJ; Jung H; Choi DK; Oh BJ; Min SH
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional improvement and maturation of human cardiomyocytes derived from human pluripotent stem cells by barbaloin preconditioning.
    Yang H; Zhong W; Hamidi MR; Zhou G; Liu C
    Acta Biochim Biophys Sin (Shanghai); 2019 Sep; 51(10):1041-1048. PubMed ID: 31518384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic Analysis of Human Pluripotent Stem Cell-Derived, Fetal, and Adult Ventricular Cardiomyocytes Reveals Pathways Crucial for Cardiac Metabolism and Maturation.
    Poon E; Keung W; Liang Y; Ramalingam R; Yan B; Zhang S; Chopra A; Moore J; Herren A; Lieu DK; Wong HS; Weng Z; Wong OT; Lam YW; Tomaselli GF; Chen C; Boheler KR; Li RA
    Circ Cardiovasc Genet; 2015 Jun; 8(3):427-36. PubMed ID: 25759434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting HIF-1α in combination with PPARα activation and postnatal factors promotes the metabolic maturation of human induced pluripotent stem cell-derived cardiomyocytes.
    Gentillon C; Li D; Duan M; Yu WM; Preininger MK; Jha R; Rampoldi A; Saraf A; Gibson GC; Qu CK; Brown LA; Xu C
    J Mol Cell Cardiol; 2019 Jul; 132():120-135. PubMed ID: 31082397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing Maturation and Translatability of Human Pluripotent Stem Cell-Derived Cardiomyocytes through a Novel Medium Containing Acetyl-CoA Carboxylase 2 Inhibitor.
    Correia C; Christoffersson J; Tejedor S; El-Haou S; Matadamas-Guzman M; Nair S; Dönnes P; Musa G; Rohman M; Sundqvist M; Riddle RB; Nugraha B; Bellido IS; Johansson M; Wang QD; Hidalgo A; Jennbacken K; Synnergren J; Später D
    Cells; 2024 Aug; 13(16):. PubMed ID: 39195229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes: a Critical Step for Drug Development and Cell Therapy.
    Tan SH; Ye L
    J Cardiovasc Transl Res; 2018 Oct; 11(5):375-392. PubMed ID: 29557052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells:
    Jiang Y; Park P; Hong SM; Ban K
    Mol Cells; 2018 Jul; 41(7):613-621. PubMed ID: 29890820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maturation of human pluripotent stem cell derived cardiomyocytes in vitro and in vivo.
    Gomez-Garcia MJ; Quesnel E; Al-Attar R; Laskary AR; Laflamme MA
    Semin Cell Dev Biol; 2021 Oct; 118():163-171. PubMed ID: 34053865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical developmental cues for the maturation of human pluripotent stem cell-derived cardiomyocytes.
    Zhu R; Blazeski A; Poon E; Costa KD; Tung L; Boheler KR
    Stem Cell Res Ther; 2014 Oct; 5(5):117. PubMed ID: 25688759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-mediated maturation of human pluripotent stem cell-derived cardiomyocytes: Towards a better model for cardiotoxicity?
    White MC; Pang L; Yang X
    Food Chem Toxicol; 2016 Dec; 98(Pt A):17-24. PubMed ID: 27265266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling cadmium-induced cardiotoxicity using human pluripotent stem cell-derived cardiomyocytes.
    Shen J; Wang X; Zhou D; Li T; Tang L; Gong T; Su J; Liang P
    J Cell Mol Med; 2018 Sep; 22(9):4221-4235. PubMed ID: 29993192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell death mechanisms of the anti-cancer drug etoposide on human cardiomyocytes isolated from pluripotent stem cells.
    Nemade H; Chaudhari U; Acharya A; Hescheler J; Hengstler JG; Papadopoulos S; Sachinidis A
    Arch Toxicol; 2018 Apr; 92(4):1507-1524. PubMed ID: 29397400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell alignment induced by anisotropic electrospun fibrous scaffolds alone has limited effect on cardiomyocyte maturation.
    Han J; Wu Q; Xia Y; Wagner MB; Xu C
    Stem Cell Res; 2016 May; 16(3):740-50. PubMed ID: 27131761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes by Inhibition of HIF1α and LDHA.
    Hu D; Linders A; Yamak A; Correia C; Kijlstra JD; Garakani A; Xiao L; Milan DJ; van der Meer P; Serra M; Alves PM; Domian IJ
    Circ Res; 2018 Oct; 123(9):1066-1079. PubMed ID: 30355156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PGC-1α activator ZLN005 promotes maturation of cardiomyocytes derived from human embryonic stem cells.
    Liu Y; Bai H; Guo F; Thai PN; Luo X; Zhang P; Yang C; Feng X; Zhu D; Guo J; Liang P; Xu Z; Yang H; Lu X
    Aging (Albany NY); 2020 Apr; 12(8):7411-7430. PubMed ID: 32343674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing flecainide block of I
    Geng L; Kong CW; Wong AOT; Shum AM; Chow MZY; Che H; Zhang C; Yau KL; Chan CW; Keung W; Li RA
    Toxicol Lett; 2018 Sep; 294():61-72. PubMed ID: 29758359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic environment in vivo as a blueprint for differentiation and maturation of human stem cell-derived cardiomyocytes.
    Slaats RH; Schwach V; Passier R
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165881. PubMed ID: 32562698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARdelta activation induces metabolic and contractile maturation of human pluripotent stem cell-derived cardiomyocytes.
    Wickramasinghe NM; Sachs D; Shewale B; Gonzalez DM; Dhanan-Krishnan P; Torre D; LaMarca E; Raimo S; Dariolli R; Serasinghe MN; Mayourian J; Sebra R; Beaumont K; Iyengar S; French DL; Hansen A; Eschenhagen T; Chipuk JE; Sobie EA; Jacobs A; Akbarian S; Ischiropoulos H; Ma'ayan A; Houten SM; Costa K; Dubois NC
    Cell Stem Cell; 2022 Apr; 29(4):559-576.e7. PubMed ID: 35325615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro Matured Human Pluripotent Stem Cell-Derived Cardiomyocytes Form Grafts With Enhanced Structure and Function in Injured Hearts.
    Dhahri W; Sadikov Valdman T; Wilkinson D; Pereira E; Ceylan E; Andharia N; Qiang B; Masoudpour H; Wulkan F; Quesnel E; Jiang W; Funakoshi S; Mazine A; Gomez-Garcia MJ; Latifi N; Jiang Y; Huszti E; Simmons CA; Keller G; Laflamme MA
    Circulation; 2022 May; 145(18):1412-1426. PubMed ID: 35089805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.